2012
DOI: 10.2174/1874471011205040292
|View full text |Cite
|
Sign up to set email alerts
|

The Emerging Role of Stereotactic Radiosurgery in the Treatment of Glioblastoma Multiforme

Abstract: Stereotactic radiosurgery is an emerging treatment option offered to patients with Glioblastoma multiforme (GBM). Radiosurgery is performed as an outpatient procedure and provides a safe and effective non invasive treatment for focal GBM. High energy beams originating from cobalt sources placed into an helmet (Gamma-Knife) or generated by a linear accelerator (LINAC) rotating on a gantry (X-Knife, Novalis) or maneuvered by a robotic arm (CyberKnife) are delivered with submillimetric accuracy to a selected intr… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
3
0

Year Published

2014
2014
2023
2023

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 7 publications
(3 citation statements)
references
References 43 publications
0
3
0
Order By: Relevance
“…Gross tumor volume less than 10.1 cm 3 was associated with a median survival of 15.1 months versus 8.1 months for larger tumors. The role of CyberKnife SRS in the treatment of GBM was recently reviewed by Barbarisi et al; the authors highlighted the value of accurate high-dose treatment either in single or multiple sessions [ 10 ]. The combination of sophisticated real-time image and robotic delivery is the basis of the CyberKnife’s precision and submillimetric accuracy and it can be employed as a primary treatment modality in patients harboring small lesions (3 cm or less in diameter), lesions located in surgically inaccessible regions, such as the thalamus, hypothalamus, and basal ganglia, or in the patients that are too ill for a surgical resection.…”
Section: Discussionmentioning
confidence: 99%
“…Gross tumor volume less than 10.1 cm 3 was associated with a median survival of 15.1 months versus 8.1 months for larger tumors. The role of CyberKnife SRS in the treatment of GBM was recently reviewed by Barbarisi et al; the authors highlighted the value of accurate high-dose treatment either in single or multiple sessions [ 10 ]. The combination of sophisticated real-time image and robotic delivery is the basis of the CyberKnife’s precision and submillimetric accuracy and it can be employed as a primary treatment modality in patients harboring small lesions (3 cm or less in diameter), lesions located in surgically inaccessible regions, such as the thalamus, hypothalamus, and basal ganglia, or in the patients that are too ill for a surgical resection.…”
Section: Discussionmentioning
confidence: 99%
“…The addition of stereotactic radiosurgery in combination to chemotherapy could have beneficial effects. Previous studies show the effectiveness of fractionated stereotactic radiosurgery (FSRS) as an option for the treatment of recurrent glioblastoma [27,28]. Combs et al reported 5 months progression-free survival after FSRT and 21 months median overall survival [29].…”
Section: Discussionmentioning
confidence: 99%
“…In our hands HDR-Brachytherapy is an approved treatment method of recurrent high grade gliomas. It offers a potential advantage over the conventional interstitial brachytherapy by means of delivering a more conformal, uniform and relatively homogeneous dose distribution, avoiding the "hot" and "cold" spots of over-and under-dosing of seed or strand brachytherapy approaches [27]. Furthermore, the catheters and subsequent treatment planning conform to the surgical cavity, and the dosimetry is precise and easily reproduced.…”
Section: Discussionmentioning
confidence: 99%